UBS Group’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Buy
1,618,884
+1,543,313
+2,042% +$1.1M ﹤0.01% 4242
2025
Q1
$49.2K Sell
75,571
-108,090
-59% -$70.4K ﹤0.01% 6317
2024
Q4
$338K Buy
183,661
+17,802
+11% +$32.8K ﹤0.01% 4945
2024
Q3
$574K Buy
165,859
+134,507
+429% +$465K ﹤0.01% 3995
2024
Q2
$91.9K Sell
31,352
-33,287
-51% -$97.5K ﹤0.01% 5101
2024
Q1
$365K Buy
64,639
+5,048
+8% +$28.5K ﹤0.01% 4314
2023
Q4
$256K Buy
59,591
+23,618
+66% +$101K ﹤0.01% 4447
2023
Q3
$125K Buy
35,973
+5,909
+20% +$20.5K ﹤0.01% 4578
2023
Q2
$140K Sell
30,064
-52,636
-64% -$245K ﹤0.01% 4703
2023
Q1
$382K Buy
82,700
+10,037
+14% +$46.4K ﹤0.01% 3891
2022
Q4
$587K Buy
72,663
+71,588
+6,659% +$578K ﹤0.01% 3575
2022
Q3
$6K Sell
1,075
-2,648
-71% -$14.8K ﹤0.01% 7959
2022
Q2
$19K Sell
3,723
-106,610
-97% -$544K ﹤0.01% 5915
2022
Q1
$907K Buy
+110,333
New +$907K ﹤0.01% 3325
2021
Q4
Sell
-1,221
Closed -$23K 9386
2021
Q3
$23K Buy
+1,221
New +$23K ﹤0.01% 5890
2021
Q2
Sell
-507
Closed -$12K 8573
2021
Q1
$12K Buy
+507
New +$12K ﹤0.01% 6782
2020
Q4
Sell
-752
Closed -$8K 7620
2020
Q3
$8K Sell
752
-4,623
-86% -$49.2K ﹤0.01% 6165
2020
Q2
$42K Sell
5,375
-1,253
-19% -$9.79K ﹤0.01% 5174
2020
Q1
$68K Sell
6,628
-6,836
-51% -$70.1K ﹤0.01% 4711
2019
Q4
$148K Buy
13,464
+4,774
+55% +$52.5K ﹤0.01% 4775
2019
Q3
$79K Buy
8,690
+6,720
+341% +$61.1K ﹤0.01% 4985
2019
Q2
$22K Buy
+1,970
New +$22K ﹤0.01% 5678
2019
Q1
Sell
-3,758
Closed -$34K 7108
2018
Q4
$34K Buy
3,758
+2,510
+201% +$22.7K ﹤0.01% 5481
2018
Q3
$19K Buy
+1,248
New +$19K ﹤0.01% 5911